Literature DB >> 16206234

Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.

Ciriana Orabona1, Elena Tomasello, Francesca Fallarino, Roberta Bianchi, Claudia Volpi, Silvia Bellocchio, Luigina Romani, Maria C Fioretti, Eric Vivier, Paolo Puccetti, Ursula Grohmann.   

Abstract

DAP12 is an immunoreceptor tyrosine-based activation motif-bearing membrane adapter molecule expressed by different cell types. Although several receptors associate with DAP12 in murine dendritic cells (DC), the function of these receptors is as yet unknown. Here we report that splenic mature DC with DAP12 overexpression are characterized by an impaired tolerogenic potential. In contrast, inhibition of DAP12 function results in enhanced tolerogenesis and constitutive expression of immunosuppressive tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO). Increased resistance to experimental encephalomyelitis is observed in DAP12 knockin mice, which is dependent on IDO expression. Therefore, DAP12-related receptors act as negative regulators of IDO-mediated tolerance in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206234     DOI: 10.1002/eji.200535289

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege.

Authors:  Lei Huang; Babak Baban; Burles A Johnson; Andrew L Mellor
Journal:  Int Rev Immunol       Date:  2010-04       Impact factor: 5.311

Review 2.  Molecular regulation of hepatic dendritic cell function and its relation to liver transplant outcome.

Authors:  Tina L Sumpter; John G Lunz; A Jake Demetris; Angus W Thomson
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

3.  Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.

Authors:  Francesca Fallarino; Claudia Volpi; Francesco Fazio; Serena Notartomaso; Carmine Vacca; Carla Busceti; Silvio Bicciato; Giuseppe Battaglia; Valeria Bruno; Paolo Puccetti; Maria C Fioretti; Ferdinando Nicoletti; Ursula Grohmann; Roberto Di Marco
Journal:  Nat Med       Date:  2010-07-25       Impact factor: 53.440

4.  DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability.

Authors:  Tina L Sumpter; Vignesh Packiam; Heth R Turnquist; Antonino Castellaneta; Osamu Yoshida; Angus W Thomson
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

Review 5.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

6.  Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.

Authors:  Bridget L Colvin; Tina L Sumpter; Daisuke Tokita; Jennifer Salati; Andrew L Mellor; Angus W Thomson
Journal:  Hum Immunol       Date:  2009-02-03       Impact factor: 2.850

Review 7.  IDO: a double-edged sword for T(H)1/T(H)2 regulation.

Authors:  Hui Xu; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Immunol Lett       Date:  2008-09-29       Impact factor: 3.685

Review 8.  T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Authors:  David J Kahler; Andrew L Mellor
Journal:  Handb Exp Pharmacol       Date:  2009

9.  TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.

Authors:  Suresh Radhakrishnan; Laura N Arneson; Jadee L Upshaw; Charles L Howe; Sara J Felts; Marco Colonna; Paul J Leibson; Moses Rodriguez; Larry R Pease
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.

Authors:  Francesca Fallarino; Giovanni Luca; Mario Calvitti; Francesca Mancuso; Claudio Nastruzzi; Maria C Fioretti; Ursula Grohmann; Ennio Becchetti; Anne Burgevin; Roland Kratzer; Peter van Endert; Louis Boon; Paolo Puccetti; Riccardo Calafiore
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.